Showing results (31-40 of 60) with videos related to
Sort By:
Pageof 6
Journal of Neurology|November 25, 2025
Motherhood and diagnostic delay among women with multiple sclerosisAlexandra Balshi, John P Dempsey, Sachin Kumbar, et al.Multiple Sclerosis and Related Disorders|May 29, 2025
Clinical characteristics associated with multiple sclerosis fatigue severityAlexandra Balshi, John P Dempsey, Nova Manning, et al.Neuroimage. Clinical|November 23, 2016
The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T2* mapping at 7 T MRICéline Louapre, Sindhuja T Govindarajan, Costanza Giannì, et al.Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|August 25, 2020
Leptomeningeal Enhancement on 3D-FLAIR MRI in Multiple Sclerosis: Systematic Observations in Clinical PracticeDavid S Titelbaum, Renate Engisch, Eric D Schwartz, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 15, 2017
Heterogeneous pathological processes account for thalamic degeneration in multiple sclerosis: Insights from 7 T imagingCéline Louapre, Sindhuja T Govindarajan, Costanza Giannì, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 26, 2020
Characterization of thalamic lesions and their correlates in multiple sclerosis by ultra-high-field MRIAmbica Mehndiratta, Constantina A Treaba, Valeria Barletta, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 26, 2006
WAVE1 is required for oligodendrocyte morphogenesis and normal CNS myelinationHyun-Ju Kim, Allitia B DiBernardo, Jacob A Sloane, et al.Journal of Neurology|February 1, 2021
The relevance of multiple sclerosis cortical lesions on cortical thinning and their clinical impact as assessed by 7.0-T MRIConstantina A Treaba, Elena Herranz, Valeria T Barletta, et al.The Journal of Cell Biology|October 25, 2006
Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosisYinghua Ma, Jianxue Li, Isaac Chiu, et al.Neurodegenerative Disease Management|February 1, 2021
CLICK-MS and MASTER-2 Phase IV trial design: cladribine tablets in suboptimally controlled relapsing multiple sclerosisAugusto A Miravalle, Joshua Katz, Derrick Robertson, et al.Pageof 6